← Back
$STOK All transactions

Stoke Therapeutics, Inc.

M

$ Value

$0

Shares

14,750

Price

$0

Filed

Mar 17

Insider

Name

Leggett Thomas

Title

Chief Financial Officer

CIK

0001774690

Roles

Officer

Transaction Details

Transaction Date

2026-03-15

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

14,750

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. | The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date.

Filing Info

Accession No.

0001774690-26-000004

Form Type

4

Issuer CIK

0001623526

Leggett Thomas's History

Date Ticker Type Value
2026-03-18 STOK $68K
2026-03-18 STOK $5K
2026-03-18 STOK $1K
2026-03-17 STOK $42K
2026-03-17 STOK $31K
2026-03-15 STOK M $0
2026-03-15 STOK M $0
2026-02-17 STOK A $0
2026-02-17 STOK A $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
LEVIN ARTHUR A $22K 2026-03-13
SMITH IAN F
Chief Executive Officer
2026-02-17
Kaye Edward M. MD 2026-03-15
TZIANABOS ARTHUR
Interim Executive Chair
$174K 2026-03-10
Hoitt Jason
Chief Patient Officer
$119K 2026-03-18
Leggett Thomas
Chief Financial Officer
$147K 2026-03-18
Krainer Adrian R. $1.6M 2026-03-10
Ticho Barry
CHIEF MEDICAL OFFICER
$517K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$599K 2026-03-20